Attention: World-2DPAGE is no longer maintained.
[Click to access protein entry]
Spot: 2D-00083K (lymphoma_human)
pI: 6.26 Mw: 25930
%vol: 0.115533 %od: 0.189603
================
*PRDX6_HUMAN*
accession n°: P30041
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-00083K (lymphoma_human)
pI: 6.26 Mw: 25930
%vol: 0.115533 %od: 0.189603
================
*PRDX6_HUMAN*
accession n°: P30041
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0008D1 (lymphoma_human)
pI: 6.35 Mw: 10459
%vol: 0.0545843 %od: 0.0844407
================
*DOPD_HUMAN*
accession n°: P30046
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0008D1 (lymphoma_human)
pI: 6.35 Mw: 10459
%vol: 0.0545843 %od: 0.0844407
================
*DOPD_HUMAN*
accession n°: P30046
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007ST (lymphoma_human)
pI: 5.22 Mw: 39009
%vol: 0.0477885 %od: 0.035234
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007ST (lymphoma_human)
pI: 5.22 Mw: 39009
%vol: 0.0477885 %od: 0.035234
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007BP (lymphoma_human)
pI: 5.62 Mw: 68230
%vol: 0.15836 %od: 0.293208
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007BP (lymphoma_human)
pI: 5.62 Mw: 68230
%vol: 0.15836 %od: 0.293208
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007PQ (lymphoma_human)
pI: 5.16 Mw: 42093
%vol: 0.154908 %od: 0.259437
================
*ACTB_HUMAN*
accession n°: P60709
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007PQ (lymphoma_human)
pI: 5.16 Mw: 42093
%vol: 0.154908 %od: 0.259437
================
*ACTB_HUMAN*
accession n°: P60709
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007FN (lymphoma_human)
pI: 7.36 Mw: 57241
%vol: 0.170981 %od: 0.187436
================
*CATA_HUMAN*
accession n°: P04040
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007FN (lymphoma_human)
pI: 7.36 Mw: 57241
%vol: 0.170981 %od: 0.187436
================
*CATA_HUMAN*
accession n°: P04040
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007NB (lymphoma_human)
pI: 5.45 Mw: 45667
%vol: 0.0734622 %od: 0.0483584
================
*QCR1_HUMAN*
accession n°: P31930
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007NB (lymphoma_human)
pI: 5.45 Mw: 45667
%vol: 0.0734622 %od: 0.0483584
================
*QCR1_HUMAN*
accession n°: P31930
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007FS (lymphoma_human)
pI: 5.25 Mw: 56710
%vol: 0.170765 %od: 0.281214
================
*CH60_HUMAN*
accession n°: P10809
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007FS (lymphoma_human)
pI: 5.25 Mw: 56710
%vol: 0.170765 %od: 0.281214
================
*CH60_HUMAN*
accession n°: P10809
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-00085X (lymphoma_human)
pI: 5.45 Mw: 22946
%vol: 0.131391 %od: 0.202613
================
*GSTP1_HUMAN*
accession n°: P09211
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-00085X (lymphoma_human)
pI: 5.45 Mw: 22946
%vol: 0.131391 %od: 0.202613
================
*GSTP1_HUMAN*
accession n°: P09211
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007ID (lymphoma_human)
pI: 5.64 Mw: 52393
%vol: 0.164616 %od: 0.168345
================
*PDIA3_HUMAN*
accession n°: P30101
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007ID (lymphoma_human)
pI: 5.64 Mw: 52393
%vol: 0.164616 %od: 0.168345
================
*PDIA3_HUMAN*
accession n°: P30101
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-00078A (lymphoma_human)
pI: 6.36 Mw: 85658
%vol: 0.149514 %od: 0.19773
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-00078A (lymphoma_human)
pI: 6.36 Mw: 85658
%vol: 0.149514 %od: 0.19773
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007W2 (lymphoma_human)
pI: 8.48 Mw: 34984
%vol: 0.200323 %od: 0.512963
================
*G3P_HUMAN*
accession n°: P04406
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007W2 (lymphoma_human)
pI: 8.48 Mw: 34984
%vol: 0.200323 %od: 0.512963
================
*G3P_HUMAN*
accession n°: P04406
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007FG (lymphoma_human)
pI: 7.59 Mw: 57241
%vol: 0.218554 %od: 0.523586
================
*CATA_HUMAN*
accession n°: P04040
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007FG (lymphoma_human)
pI: 7.59 Mw: 57241
%vol: 0.218554 %od: 0.523586
================
*CATA_HUMAN*
accession n°: P04040
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007C2 (lymphoma_human)
pI: 5.84 Mw: 67612
%vol: 0.18015 %od: 0.185096
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007C2 (lymphoma_human)
pI: 5.84 Mw: 67612
%vol: 0.18015 %od: 0.185096
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0008CT (lymphoma_human)
pI: 4.88 Mw: 11056
%vol: 0.0703343 %od: 0.0912199
================
*THIO_HUMAN*
accession n°: P10599
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0008CT (lymphoma_human)
pI: 4.88 Mw: 11056
%vol: 0.0703343 %od: 0.0912199
================
*THIO_HUMAN*
accession n°: P10599
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000832 (lymphoma_human)
pI: 5.66 Mw: 26479
%vol: 0.0375403 %od: 0.0410434
================
*ERP29_HUMAN*
accession n°: P30040
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000832 (lymphoma_human)
pI: 5.66 Mw: 26479
%vol: 0.0375403 %od: 0.0410434
================
*ERP29_HUMAN*
accession n°: P30040
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-00089K (lymphoma_human)
pI: 7.11 Mw: 14927
%vol: 0.229988 %od: 0.430383
================
*PPIA_HUMAN*
accession n°: P62937
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-00089K (lymphoma_human)
pI: 7.11 Mw: 14927
%vol: 0.229988 %od: 0.430383
================
*PPIA_HUMAN*
accession n°: P62937
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0008BC (lymphoma_human)
pI: 4.53 Mw: 13414
%vol: 0.0370009 %od: 0.0470434
================
*ATPD_HUMAN*
accession n°: P30049
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0008BC (lymphoma_human)
pI: 4.53 Mw: 13414
%vol: 0.0370009 %od: 0.0470434
================
*ATPD_HUMAN*
accession n°: P30049
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-00081C (lymphoma_human)
pI: 4.54 Mw: 28196
%vol: 0.0720602 %od: 0.0764385
================
*EF1B_HUMAN*
accession n°: P24534
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-00081C (lymphoma_human)
pI: 4.54 Mw: 28196
%vol: 0.0720602 %od: 0.0764385
================
*EF1B_HUMAN*
accession n°: P24534
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007BI (lymphoma_human)
pI: 5.71 Mw: 67921
%vol: 0.189751 %od: 0.493651
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007BI (lymphoma_human)
pI: 5.71 Mw: 67921
%vol: 0.189751 %od: 0.493651
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007GG (lymphoma_human)
pI: 4.87 Mw: 55663
%vol: 0.103452 %od: 0.0932911
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007GG (lymphoma_human)
pI: 4.87 Mw: 55663
%vol: 0.103452 %od: 0.0932911
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007FR (lymphoma_human)
pI: 5.18 Mw: 56842
%vol: 0.0475725 %od: 0.0224286
================
*CH60_HUMAN*
accession n°: P10809
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007FR (lymphoma_human)
pI: 5.18 Mw: 56842
%vol: 0.0475725 %od: 0.0224286
================
*CH60_HUMAN*
accession n°: P10809
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007QZ (lymphoma_human)
pI: 4.90 Mw: 40848
%vol: 0.0504853 %od: 0.0535431
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007QZ (lymphoma_human)
pI: 4.90 Mw: 40848
%vol: 0.0504853 %od: 0.0535431
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007S2 (lymphoma_human)
pI: 5.21 Mw: 39751
%vol: 0.0469254 %od: 0.0391201
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007S2 (lymphoma_human)
pI: 5.21 Mw: 39751
%vol: 0.0469254 %od: 0.0391201
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-00083E (lymphoma_human)
pI: 5.91 Mw: 26093
%vol: 0.0347356 %od: 0.0316867
================
*ECHM_HUMAN*
accession n°: P30084
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-00083E (lymphoma_human)
pI: 5.91 Mw: 26093
%vol: 0.0347356 %od: 0.0316867
================
*ECHM_HUMAN*
accession n°: P30084
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007RB (lymphoma_human)
pI: 5.05 Mw: 40592
%vol: 0.0537216 %od: 0.0325732
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007RB (lymphoma_human)
pI: 5.05 Mw: 40592
%vol: 0.0537216 %od: 0.0325732
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007H6 (lymphoma_human)
pI: 4.74 Mw: 54509
%vol: 0.163106 %od: 0.164769
================
*PDIA1_HUMAN*
accession n°: P07237
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007H6 (lymphoma_human)
pI: 4.74 Mw: 54509
%vol: 0.163106 %od: 0.164769
================
*PDIA1_HUMAN*
accession n°: P07237
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-00080N (lymphoma_human)
pI: 6.30 Mw: 29218
%vol: 0.103452 %od: 0.0798412
================
*PBLD_HUMAN*
accession n°: P30039
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-00080N (lymphoma_human)
pI: 6.30 Mw: 29218
%vol: 0.103452 %od: 0.0798412
================
*PBLD_HUMAN*
accession n°: P30039
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007VX (lymphoma_human)
pI: 8.99 Mw: 35057
%vol: 0.23398 %od: 0.645759
================
*G3P_HUMAN*
accession n°: P04406
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007VX (lymphoma_human)
pI: 8.99 Mw: 35057
%vol: 0.23398 %od: 0.645759
================
*G3P_HUMAN*
accession n°: P04406
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-00078N (lymphoma_human)
pI: 6.47 Mw: 84882
%vol: 0.193203 %od: 0.258102
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-00078N (lymphoma_human)
pI: 6.47 Mw: 84882
%vol: 0.193203 %od: 0.258102
================
*TRFE_HUMAN*
accession n°: P02787
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007BJ (lymphoma_human)
pI: 5.80 Mw: 67000
%vol: 0.192987 %od: 1.08381
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007BJ (lymphoma_human)
pI: 5.80 Mw: 67000
%vol: 0.192987 %od: 1.08381
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0008AN (lymphoma_human)
pI: 5.44 Mw: 13985
%vol: 0.0503776 %od: 0.0754851
================
*TTHY_HUMAN*
accession n°: P02766
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0008AN (lymphoma_human)
pI: 5.44 Mw: 13985
%vol: 0.0503776 %od: 0.0754851
================
*TTHY_HUMAN*
accession n°: P02766
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007HH (lymphoma_human)
pI: 5.00 Mw: 53878
%vol: 0.200107 %od: 0.287428
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007HH (lymphoma_human)
pI: 5.00 Mw: 53878
%vol: 0.200107 %od: 0.287428
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007WO (lymphoma_human)
pI: 5.63 Mw: 33973
%vol: 0.136893 %od: 0.410361
================
*CATD_HUMAN*
accession n°: P07339
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007WO (lymphoma_human)
pI: 5.63 Mw: 33973
%vol: 0.136893 %od: 0.410361
================
*CATD_HUMAN*
accession n°: P07339
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0008C5 (lymphoma_human)
pI: 8.87 Mw: 12700
%vol: 0.299136 %od: 0.920895
================
*HBA_HUMAN*
accession n°: P69905
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0008C5 (lymphoma_human)
pI: 8.87 Mw: 12700
%vol: 0.299136 %od: 0.920895
================
*HBA_HUMAN*
accession n°: P69905
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007QH (lymphoma_human)
pI: 4.90 Mw: 41625
%vol: 0.0355986 %od: 0.0181677
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007QH (lymphoma_human)
pI: 4.90 Mw: 41625
%vol: 0.0355986 %od: 0.0181677
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-00089L (lymphoma_human)
pI: 7.54 Mw: 14849
%vol: 0.244012 %od: 0.604867
================
*PPIA_HUMAN*
accession n°: P62937
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-00089L (lymphoma_human)
pI: 7.54 Mw: 14849
%vol: 0.244012 %od: 0.604867
================
*PPIA_HUMAN*
accession n°: P62937
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0008CD (lymphoma_human)
pI: 4.89 Mw: 12353
%vol: 0.0580365 %od: 0.058879
================
*COX5A_HUMAN*
accession n°: P20674
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0008CD (lymphoma_human)
pI: 4.89 Mw: 12353
%vol: 0.0580365 %od: 0.058879
================
*COX5A_HUMAN*
accession n°: P20674
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-00086N (lymphoma_human)
pI: 4.81 Mw: 21724
%vol: 0.0426104 %od: 0.0444527
================
*TCTP_HUMAN*
accession n°: P13693
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-00086N (lymphoma_human)
pI: 4.81 Mw: 21724
%vol: 0.0426104 %od: 0.0444527
================
*TCTP_HUMAN*
accession n°: P13693
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007FO (lymphoma_human)
pI: 5.13 Mw: 56842
%vol: 0.028371 %od: 0.0175529
================
*CH60_HUMAN*
accession n°: P10809
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007FO (lymphoma_human)
pI: 5.13 Mw: 56842
%vol: 0.028371 %od: 0.0175529
================
*CH60_HUMAN*
accession n°: P10809
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007H1 (lymphoma_human)
pI: 4.92 Mw: 54763
%vol: 0.183279 %od: 0.261252
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007H1 (lymphoma_human)
pI: 4.92 Mw: 54763
%vol: 0.183279 %od: 0.261252
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0008BY (lymphoma_human)
pI: 7.06 Mw: 12700
%vol: 0.259114 %od: 1.34525
================
*HBB_HUMAN*
accession n°: P68871
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0008BY (lymphoma_human)
pI: 7.06 Mw: 12700
%vol: 0.259114 %od: 1.34525
================
*HBB_HUMAN*
accession n°: P68871
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007RW (lymphoma_human)
pI: 5.06 Mw: 39918
%vol: 0.0537216 %od: 0.0626408
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007RW (lymphoma_human)
pI: 5.06 Mw: 39918
%vol: 0.0537216 %od: 0.0626408
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-000851 (lymphoma_human)
pI: 5.50 Mw: 24300
%vol: 0.064509 %od: 0.0644056
================
*PSB4_HUMAN*
accession n°: P28070
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-000851 (lymphoma_human)
pI: 5.50 Mw: 24300
%vol: 0.064509 %od: 0.0644056
================
*PSB4_HUMAN*
accession n°: P28070
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-00086T (lymphoma_human)
pI: 5.43 Mw: 21387
%vol: 0.0432576 %od: 0.0458894
================
*KCY_HUMAN*
accession n°: P30085
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-00086T (lymphoma_human)
pI: 5.43 Mw: 21387
%vol: 0.0432576 %od: 0.0458894
================
*KCY_HUMAN*
accession n°: P30085
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007C1 (lymphoma_human)
pI: 5.54 Mw: 67921
%vol: 0.0974107 %od: 0.150434
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007C1 (lymphoma_human)
pI: 5.54 Mw: 67921
%vol: 0.0974107 %od: 0.150434
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007W8 (lymphoma_human)
pI: 8.28 Mw: 34984
%vol: 0.177777 %od: 0.249913
================
*G3P_HUMAN*
accession n°: P04406
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007W8 (lymphoma_human)
pI: 8.28 Mw: 34984
%vol: 0.177777 %od: 0.249913
================
*G3P_HUMAN*
accession n°: P04406
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-00086J (lymphoma_human)
pI: 7.00 Mw: 21952
%vol: 0.100431 %od: 0.0939585
================
*SODM_HUMAN*
accession n°: P04179
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-00086J (lymphoma_human)
pI: 7.00 Mw: 21952
%vol: 0.100431 %od: 0.0939585
================
*SODM_HUMAN*
accession n°: P04179
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007WB (lymphoma_human)
pI: 8.74 Mw: 34837
%vol: 0.23905 %od: 0.538551
================
*G3P_HUMAN*
accession n°: P04406
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007WB (lymphoma_human)
pI: 8.74 Mw: 34837
%vol: 0.23905 %od: 0.538551
================
*G3P_HUMAN*
accession n°: P04406
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007T4 (lymphoma_human)
pI: 5.34 Mw: 38683
%vol: 0.0408844 %od: 0.0362828
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007T4 (lymphoma_human)
pI: 5.34 Mw: 38683
%vol: 0.0408844 %od: 0.0362828
================
*HPT_HUMAN*
accession n°: P00738
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007HT (lymphoma_human)
pI: 5.08 Mw: 53503
%vol: 0.193958 %od: 0.382265
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007HT (lymphoma_human)
pI: 5.08 Mw: 53503
%vol: 0.193958 %od: 0.382265
================
*A1AT_HUMAN*
accession n°: P01009
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007BV (lymphoma_human)
pI: 5.89 Mw: 68230
%vol: 0.158683 %od: 0.208689
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007BV (lymphoma_human)
pI: 5.89 Mw: 68230
%vol: 0.158683 %od: 0.208689
================
*ALBU_HUMAN*
accession n°: P02768
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-00086F (lymphoma_human)
pI: 4.75 Mw: 21895
%vol: 0.0227615 %od: 0.0432067
================
*TCTP_HUMAN*
accession n°: P13693
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-00086F (lymphoma_human)
pI: 4.75 Mw: 21895
%vol: 0.0227615 %od: 0.0432067
================
*TCTP_HUMAN*
accession n°: P13693
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007FM (lymphoma_human)
pI: 7.12 Mw: 57374
%vol: 0.080043 %od: 0.054102
================
*CATA_HUMAN*
accession n°: P04040
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007FM (lymphoma_human)
pI: 7.12 Mw: 57374
%vol: 0.080043 %od: 0.054102
================
*CATA_HUMAN*
accession n°: P04040
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-00085T (lymphoma_human)
pI: 5.25 Mw: 23006
%vol: 0.0450916 %od: 0.0749311
================
*CATB_HUMAN*
accession n°: P07858
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-00085T (lymphoma_human)
pI: 5.25 Mw: 23006
%vol: 0.0450916 %od: 0.0749311
================
*CATB_HUMAN*
accession n°: P07858
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007EP (lymphoma_human)
pI: 4.40 Mw: 59000
%vol: 0.0899673 %od: 0.0966413
================
*CALR_HUMAN*
accession n°: P27797
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007EP (lymphoma_human)
pI: 4.40 Mw: 59000
%vol: 0.0899673 %od: 0.0966413
================
*CALR_HUMAN*
accession n°: P27797
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-00085N (lymphoma_human)
pI: 5.28 Mw: 23247
%vol: 0.0450916 %od: 0.0632533
================
*APOA1_HUMAN*
accession n°: P02647
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-00085N (lymphoma_human)
pI: 5.28 Mw: 23247
%vol: 0.0450916 %od: 0.0632533
================
*APOA1_HUMAN*
accession n°: P02647
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007VR (lymphoma_human)
pI: 9.24 Mw: 35278
%vol: 0.204098 %od: 0.348326
================
*G3P_HUMAN*
accession n°: P04406
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007VR (lymphoma_human)
pI: 9.24 Mw: 35278
%vol: 0.204098 %od: 0.348326
================
*G3P_HUMAN*
accession n°: P04406
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0007PE (lymphoma_human)
pI: 5.26 Mw: 41800
%vol: 0.230204 %od: 0.815965
================
*ACTB_HUMAN*
accession n°: P60709
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0007PE (lymphoma_human)
pI: 5.26 Mw: 41800
%vol: 0.230204 %od: 0.815965
================
*ACTB_HUMAN*
accession n°: P60709
Identification Methods:
* MAPPING: {Gm}
[Click to access protein entry]
Spot: 2D-0008C4 (lymphoma_human)
pI: 6.92 Mw: 12583
%vol: 0.210139 %od: 0.452785
================
*HBB_HUMAN*
accession n°: P68871
Identification Methods:
* MAPPING: {Gm}
Spot: 2D-0008C4 (lymphoma_human)
pI: 6.92 Mw: 12583
%vol: 0.210139 %od: 0.452785
================
*HBB_HUMAN*
accession n°: P68871
Identification Methods:
* MAPPING: {Gm}
SWISS-2DPAGE Viewer
|
Back to the search engine |
-Get more information by dragging your mouse pointer over any highlighted spot -Click on a highlighted spot to access all its associated protein entries
Back to the
search engine